Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Q: When will Biodesix (BDSX) present at Canaccord Genuity’s 46th Annual Growth Conference?

Biodesix will present in a fireside chat on Wednesday, August 12, 2026 at 3:30 PM ET . According to Biodesix, this appearance is part of Canaccord Genuity’s 46th Annual Growth Conference in Boston, Massachusetts.

Q: Where is Biodesix’s fireside chat at the Canaccord Genuity 2026 Growth Conference being held?

The Biodesix fireside chat will take place at the InterContinental Boston in Boston, MA . According to Biodesix, this venue hosts Canaccord Genuity’s 46th Annual Growth Conference from August 11-12, 2026.

Q: How can investors watch Biodesix’s (BDSX) webcast from the Canaccord Genuity Growth Conference?

Investors can watch the Biodesix presentation via a live webcast with replay access. According to Biodesix, it will be available under “News & Events” in the Investors section of the company’s website at Biodesix.com.

Q: Will Biodesix (BDSX) hold investor meetings at Canaccord Genuity’s 46th Annual Growth Conference?

Yes, Biodesix leadership will host in-person 1x1 investor meetings during the conference. According to Biodesix, these meetings will complement the scheduled fireside chat on August 12, 2026 in Boston.

Q: What is Biodesix’s business focus highlighted around the Canaccord Genuity 2026 conference?

Biodesix focuses on diagnostic solutions , including Nodify Lung nodule risk assessment and IQLung cancer treatment guidance. According to Biodesix, these tests support personalized care and outcomes for patients with lung disease and are supported by its development services.

Q: Where can media and investors find contact information for Biodesix (BDSX) regarding the conference?

Media can contact Natalie St. Denis , Director of Corporate Communications, and investors can contact Chris Brinzey at ICR. According to Biodesix, their email addresses and phone numbers are provided in the announcement for direct inquiries.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Biodesix (Nasdaq: BDSX) announced that its leadership team will participate in Canaccord Genuity’s 46th Annual Growth Conference, held August 11-12, 2026, at the InterContinental Boston in Boston, MA. The team will take part in a fireside chat and host in-person 1x1 investor meetings.

The fireside chat is scheduled for Wednesday, August 12, 2026 at 3:30 PM ET. According to Biodesix, the presentation will be webcast live and made available for replay under “News & Events” in the Investors section of its website at Biodesix.com.

Market Reaction – BDSX

+1.75% $22.41

15m delay

+1.75% Vs previous close

$22.41 Last Price

$22.00 $23.39 Day Range

$232.13M Market Cap

0.7x Rel. Volume

Following this news, BDSX has gained 1.75%, reflecting a mild positive market reaction. Our momentum scanner has triggered 3 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $22.41.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

An active S-3 registers resale of up to 375,000 shares, and current short positioning is classified ...

Analysis

An active S-3 registers resale of up to 375,000 shares, and current short positioning is classified as low. This conference notice contains no operating metrics; the scheduled presentation is the stated venue for further company disclosures.

Key Figures

Conference number: 46th Conference dates: August 11-12, 2026 Fireside chat date: August 12, 2026 +2 more

5 metrics

Conference number 46th Canaccord Genuity Growth Conference

Conference dates August 11-12, 2026 Canaccord Genuity’s 46th Annual Growth Conference

Fireside chat date August 12, 2026 Biodesix conference presentation

Fireside chat time 3:30 PM ET August 12, 2026

Investor meetings 1x1 In-person investor meetings at the conference

Historical Context

5 past events · Latest: Jul 22 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 22	Earnings date notice	Neutral	+1.2%	Announced second-quarter 2026 results release and conference call timing
May 21	Conference participation	Neutral	+5.6%	Announced participation in three upcoming investor conferences
May 11	Clinical data presentation	Neutral	+5.2%	Announced real-world clinical and economic data presentations at ATS 2026
May 04	First-quarter earnings	Positive	+32.6%	Reported revenue growth, improved losses, and raised full-year revenue guidance
Apr 20	Earnings date notice	Neutral	+0.2%	Scheduled first-quarter 2026 results release and management conference call

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Listed prior events all had positive 24-hour reactions, including the prior conference and clinical-data announcements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/04/2026 - 06:00 AM

LOUISVILLE, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will present in a fireside chat and host in-person 1x1 investor meetings at Canaccord Genuity’s 46^th Annual Growth Conference, which will be held from August 11-12, 2026.

Canaccord Genuity’s 46^th Annual Growth Conference
Fireside Chat Date: Wednesday, August 12, 2026
Fireside Chat Time: 3:30 PM ET
Location: InterContinental Boston, Boston, MA

The presentation will be webcast live and available for replay under “News & Events” in the Investors section of Biodesix website at Biodesix.com.

About Biodesix:

Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, including Nodify Lung^® Nodule Risk Assessment and IQLung^® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com.

Biodesix Contacts:
Media:
Natalie St. Denis, Director Corporate Communications
natalie.stdenis@biodesix.com
(720) 925-9285

Investors:
Chris Brinzey, Partner, ICR
chris.brinzey@icrhealthcare.com
(339) 970-2843

FAQ

When will Biodesix (BDSX) present at Canaccord Genuity’s 46th Annual Growth Conference?

Biodesix will present in a fireside chat on Wednesday, August 12, 2026 at 3:30 PM ET. According to Biodesix, this appearance is part of Canaccord Genuity’s 46th Annual Growth Conference in Boston, Massachusetts.

Where is Biodesix’s fireside chat at the Canaccord Genuity 2026 Growth Conference being held?

The Biodesix fireside chat will take place at the InterContinental Boston in Boston, MA. According to Biodesix, this venue hosts Canaccord Genuity’s 46th Annual Growth Conference from August 11-12, 2026.

How can investors watch Biodesix’s (BDSX) webcast from the Canaccord Genuity Growth Conference?

Investors can watch the Biodesix presentation via a live webcast with replay access. According to Biodesix, it will be available under “News & Events” in the Investors section of the company’s website at Biodesix.com.

Will Biodesix (BDSX) hold investor meetings at Canaccord Genuity’s 46th Annual Growth Conference?

Yes, Biodesix leadership will host in-person 1x1 investor meetings during the conference. According to Biodesix, these meetings will complement the scheduled fireside chat on August 12, 2026 in Boston.

What is Biodesix’s business focus highlighted around the Canaccord Genuity 2026 conference?

Biodesix focuses on diagnostic solutions, including Nodify Lung nodule risk assessment and IQLung cancer treatment guidance. According to Biodesix, these tests support personalized care and outcomes for patients with lung disease and are supported by its development services.

Where can media and investors find contact information for Biodesix (BDSX) regarding the conference?

Media can contact Natalie St. Denis, Director of Corporate Communications, and investors can contact Chris Brinzey at ICR. According to Biodesix, their email addresses and phone numbers are provided in the announcement for direct inquiries.